GLP-1 Agent May Hold Opioid Use Disorder Benefit Researchers highlight semaglutide's potential value for preventing overdoses Sep 26, 2024
One-Year CGM Cleared; Osteoporosis Lawsuits Revived; Chemicals and Early Puberty News and commentary from the endocrinology world Sep 24, 2024
FTC Sues Top Pharmacy Benefit Managers Over Insulin Prices The three companies process about 80% of prescriptions in the U.S. Sep 20, 2024
FDA Rejects NK1R Antagonist for Gastroparesis Drugmaker none-too-pleased with agency's request for additional studies Sep 19, 2024
Coffee and Heart, Metabolic Risks; What Drives Doctors Away; Ozempic for $100? Health news and commentary gathered by app staff Sep 18, 2024
GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, Death Limited benefit seen in patients with established cirrhosis, however Sep 16, 2024
What Factors Predict Clinically Meaningful Weight Loss With GLP-1 Agonists? Researcher discusses weight outcomes for those taking semaglutide or liraglutide Sep 16, 2024 video
Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening More noteworthy research from the EASD 2024 meeting Sep 13, 2024
8-Hour Eating Window Improved Glycemic Control, Small Study Shows Three-day intervention boosted time spent in normal glucose range Sep 13, 2024
Direct-to-Consumer Drugs: Big Pharma's Digital Health Play Regulators will need to closely watch this new frontier Sep 13, 2024
Microvascular Diabetes Complications Linked to Moderate/Severe Gum Disease Relationship was mediated by comorbid dyslipidemia Sep 11, 2024
Steroid Use Tied to Diabetes; Suicide Rates Climbing; Legionnaire's Death Toll Rises Health news and commentary gathered by app staff Sep 11, 2024
Weekly Insulin Efsitora Noninferior to Daily Degludec in Type 1, Type 2 Diabetes But higher severe hypoglycemia risk with efsitora in type 1 diabetes likely precludes its use Sep 10, 2024
FreeStyle Libre 3 Sensor Class I Recall; Second OTC CGM Cleared; Weekly Insulin Win News and commentary from the endocrinology world Sep 09, 2024
New Studies Fuel Debate Over GLP-1 Drugs and Suicide Risk No link found in nationwide data from Sweden and Denmark and in analysis of STEP trials Sep 03, 2024
Meat Types and T2D; Semaglutide in Heart Failure; Acromegaly at the Paralympics News and commentary from the endocrinology world Sep 03, 2024
GLP-1 Agonists May Offer Protection Against Glaucoma in Type 2 Diabetes Significant reductions in glaucoma, ocular hypertension, prescriptions versus metformin Aug 28, 2024
T1D Stem Cell Success Story; Lilly's Discount Tirzepatide Vials; Stelo Now Available News and commentary from the endocrinology world Aug 27, 2024
FDA Clears First Automated Insulin-Delivery Tech for Type 2 Diabetes SmartAdjust technology is used in Insulet's Omnipod 5 Automated Insulin Delivery System Aug 27, 2024
Matthew Perry's Doc Reopens Clinic; Trump's Medical Records; Drug Cuts Diabetes Risk Health news and commentary gathered by app staff Aug 21, 2024
Semaglutide Has Disproportionate Suicidality Signal, Analysis Finds Reports of suicidal ideation higher when compared to other drugs in WHO database Aug 20, 2024
Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update News and commentary from the endocrinology world Aug 20, 2024
Here's How Compounders Make Popular Weight-Loss Drugs From sourcing API to getting the final formulation just right Aug 19, 2024
Is Medicare's Negotiated Drug Price List Worth Celebrating? Depends on Whom You Ask. Reactions from physician and consumer groups were positive, but drugmakers begged to differ Aug 16, 2024
Disposable CGM Approved; Mounjaro Tied to Reduced Mortality; Benefits of Lignins News and commentary from the endocrinology world Aug 13, 2024
GLP-1 Agonists for Diabetes Tied to Lower Hyperkalemia Rates Class was compared with DPP4-inhibitors Aug 12, 2024
Dementia Risk Dropped With Anti-Inflammatory Diet for Certain Patients Brain markers of degeneration, injury were better, too Aug 12, 2024
What's the Best Way to Help Specialists Succeed? Beef Up Primary Care Let us handle the garden-variety hypertension and diabetes, and give them the complex cases Aug 12, 2024
Eating Disorders After GLP-1s? Tirzepatide for Heart Failure; Soda Taxes and BMI News and commentary from the endocrinology world Aug 06, 2024
Poor Physical Function Likely the Main Reason for Higher Fracture Risk in T2D Skeletal characteristics may not be to blame among older women Aug 06, 2024
Prescription-Free Online Semaglutide Is Risky Business Over 40% of pharmacy sites offering GLP-1 drug without a script are known to operate illegally Aug 05, 2024
Aerosmith Retires After Injury; All Zepbound Doses Now Available; Guacamole Recalled Health news and commentary gathered by app staff Aug 05, 2024
NIH Loses in Court; NSYNC Member's New Diagnosis; Chief Resident Dies at 32 Health news and commentary gathered by app staff Aug 02, 2024
Semaglutide May Help Smokers Quit, Study Suggests Use for diabetes tied to fewer medical visits for tobacco use disorder versus other antidiabetics Jul 30, 2024
Faulty FreeStyle Libre 3 Sensors; Endocrine Society Merger; More Levemir Pushback News and commentary from the endocrinology world Jul 30, 2024
Hint of Alzheimer's Benefit Seen With GLP-1 Drug Slower cognitive decline, less brain volume loss in early liraglutide study Jul 30, 2024
FDA Warns of Overdoses With Compounded Semaglutide Multi-dose vials pose complications for self-administration Jul 29, 2024
Kim Jong Un's Health Problems; Seine Olympic Event Nixed Again; Vegan Diet and Aging Health news and commentary gathered by app staff Jul 29, 2024
Can App Data Link Sleep and Chronic Disease?; AI Model to Manage Diabetes Also in TTHealthWatch: a monoclonal antibody for ulcerative colitis Jul 27, 2024 podcast